156 related articles for article (PubMed ID: 10722622)
1. Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.
Kumar S; Collins W; Egan A; Yadava A; Garraud O; Blackman MJ; Guevara Patino JA; Diggs C; Kaslow DC
Infect Immun; 2000 Apr; 68(4):2215-23. PubMed ID: 10722622
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.
Stowers AW; Cioce V; Shimp RL; Lawson M; Hui G; Muratova O; Kaslow DC; Robinson R; Long CA; Miller LH
Infect Immun; 2001 Mar; 69(3):1536-46. PubMed ID: 11179324
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
[TBL] [Abstract][Full Text] [Related]
5. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
Chang SP; Case SE; Gosnell WL; Hashimoto A; Kramer KJ; Tam LQ; Hashiro CQ; Nikaido CM; Gibson HL; Lee-Ng CT; Barr PJ; Yokota BT; Hut GS
Infect Immun; 1996 Jan; 64(1):253-61. PubMed ID: 8557348
[TBL] [Abstract][Full Text] [Related]
6. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
Darko CA; Angov E; Collins WE; Bergmann-Leitner ES; Girouard AS; Hitt SL; McBride JS; Diggs CL; Holder AA; Long CA; Barnwell JW; Lyon JA
Infect Immun; 2005 Jan; 73(1):287-97. PubMed ID: 15618165
[TBL] [Abstract][Full Text] [Related]
7. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
Egan AF; Blackman MJ; Kaslow DC
Infect Immun; 2000 Mar; 68(3):1418-27. PubMed ID: 10678955
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
[TBL] [Abstract][Full Text] [Related]
9. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.
Singh S; Kennedy MC; Long CA; Saul AJ; Miller LH; Stowers AW
Infect Immun; 2003 Dec; 71(12):6766-74. PubMed ID: 14638762
[TBL] [Abstract][Full Text] [Related]
11. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.
Hisaeda H; Saul A; Reece JJ; Kennedy MC; Long CA; Miller LH; Stowers AW
J Infect Dis; 2002 Mar; 185(5):657-64. PubMed ID: 11865423
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys.
Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722
[TBL] [Abstract][Full Text] [Related]
13. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
Enders B; Hundt E; Knapp B
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
[TBL] [Abstract][Full Text] [Related]
14. Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.
Collins WE; Galland GG; Barnwell JW; Udhayakumar V; Sullivan JS; Nace D; Tongren JE; Williams T; Roberts J; Shi YP; Lal AA
Am J Trop Med Hyg; 2005 Oct; 73(4):686-93. PubMed ID: 16222010
[TBL] [Abstract][Full Text] [Related]
15. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
Hui GS; Nikaido C; Hashiro C; Kaslow DC; Collins WE
Infect Immun; 1996 May; 64(5):1502-9. PubMed ID: 8613353
[TBL] [Abstract][Full Text] [Related]
16. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.
Lyon JA; Angov E; Fay MP; Sullivan JS; Girourd AS; Robinson SJ; Bergmann-Leitner ES; Duncan EH; Darko CA; Collins WE; Long CA; Barnwell JW
PLoS One; 2008 Jul; 3(7):e2830. PubMed ID: 18665258
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).
Rosa DS; Iwai LK; Tzelepis F; Bargieri DY; Medeiros MA; Soares IS; Sidney J; Sette A; Kalil J; Mello LE; Cunha-Neto E; Rodrigues MM
Microbes Infect; 2006 Jul; 8(8):2130-7. PubMed ID: 16797207
[TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
[TBL] [Abstract][Full Text] [Related]
20. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
Burghaus PA; Wellde BT; Hall T; Richards RL; Egan AF; Riley EM; Ballou WR; Holder AA
Infect Immun; 1996 Sep; 64(9):3614-9. PubMed ID: 8751907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
